Current pharmacotherapy options for osteomyelitis: convergences, divergences and lessons to be drawn. | Expert Opin Pharmacother;14(6): 723-34, 2013 Apr. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

Virtual Health Library

United States - Mexico Border

Subject descriptor lookup Advanced Search

Current pharmacotherapy options for osteomyelitis: convergences, divergences and lessons to be drawn.

Senneville, Eric; Nguyen, Sophie.

Affiliation

Senneville E; Gustave Dron Hospital, Infectious Diseases Department, 135 rue du Président Coty 59200 Tourcoing, France. esenneville@ch-tourcoing.fr

Expert Opin Pharmacother ; 14(6): 723-34, 2013 Apr.

Article in En | MEDLINE | ID: mdl-23496344

Subject(s)

Anti-Bacterial Agents/therapeutic use; Diabetic Foot/drug therapy; Osteomyelitis/drug therapy; Acute Disease; Adult; Animals; Anti-Bacterial Agents/pharmacology; Chronic Disease; Diabetic Foot/microbiology; Drug Design; Humans; Osteomyelitis/microbiology

Search on Google

Full text: 1 Database: MEDLINE Main subject: Osteomyelitis / Diabetic Foot / Anti-Bacterial Agents Type of study: Prognostic_studies Limits: Adult / Animals / Humans Language: En Year: 2013 Type: Article

Search on Google

Full text: 1 Database: MEDLINE Main subject: Osteomyelitis / Diabetic Foot / Anti-Bacterial Agents Type of study: Prognostic_studies Limits: Adult / Animals / Humans Language: En Year: 2013 Type: Article